SCHEMBL7566917

SCHEMBL7566917

CCCCOc1ccccc1N1CCN(C(Cc2ccc(C#N)c(F)c2)c2cnc(C)[nH]2)CC1=O

nearest known ligand 0.32

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
BCAT2 O15382 1/20 0.32
BCAT1 P54687 1/20 0.32
PRMT5 O14744 1/20 0.31
WDR77 Q9BQA1 1/20 0.31
GPR52 Q9Y2T5 1/20 0.31
XDH P47989 1/20 0.30
CACNA1H O95180 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3498917 0.87 FFAR4 (0.34) BCAT2BCAT1
Hydrochloric Acid SCHEMBL7527027 0.86 FFAR4 (0.33) BCAT2BCAT1
SCHEMBL3499837 0.85 FNTA (0.44) BCAT2BCAT1
Hydrochloric Acid SCHEMBL7588892 0.85 FNTA (0.44) BCAT2BCAT1
SCHEMBL6409378 0.82 HTR1A (0.35)
SCHEMBL6411741 0.82 FNTA (0.34) PRMT5WDR77GPR52
SCHEMBL7566909 0.75 FNTA (0.41)
SCHEMBL6409385 0.74 PRMT5 (0.36) PRMT5WDR77GPR52CACNA1H
SCHEMBL6413460 0.72 PRMT5 (0.32) PRMT5WDR77
SCHEMBL6408970 0.72 PRMT5 (0.31) PRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020052380-A1 Inhibitors of prenyl-protein transferase DINSMORE CHRISTOPHER J (US) 2002-05-02 US disclosed
US-20020010184-A1 Inhibitors of prenyl-protein transferase DINSMORE CHRISTOPHER J (US) 2002-01-24 US disclosed
WO-2001060368-A1 INHIBITORS OF PRENYL-PROTEIN TRANSFERASE MERCK & CO., INC. (US) 2001-08-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020010184-A1 Inhibitors of prenyl-protein transferase FNTA, FNTB, ZMPSTE24 BCAT2 2130/4885BCAT1 1397/4885PRMT5 657/4885
US-20020052380-A1 Inhibitors of prenyl-protein transferase FNTA, FNTB, GGPS1 BCAT2 1045/4885BCAT1 334/4885PRMT5 360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.